Edwards Lifesciences Corporation (EW) Q2 2026 Earnings Call Transcript

Edwards Lifesciences Corporation (EW) Q2 2026 Earnings Call July 23, 2026 5:00 PM EDT

Company Participants

Gerianne Sarte - Investor Relations Officer

Bernard Zovighian - CEO & Director

Theodora Mistras - Corporate VP & CFO

Daniel Lippis - Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific)

Daveen Chopra - Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies

Conference Call Participants

Robert Marcus - JPMorgan Chase & Co, Research Division

Larry Biegelsen - Wells Fargo Securities, LLC, Research Division

Travis Steed - BofA Securities, Research Division

Joanne Wuensch - Citigroup Inc., Research Division

Pito Chickering - Deutsche Bank AG, Research Division

Vijay Kumar - Evercore ISI Institutional Equities, Research Division

Joshua Jennings - TD Cowen, Research Division

Operator Greetings, and welcome to the Edwards Lifesciences Second Quarter 2026 Earnings Conference Call.

Operator [Operator Instructions]

Operator As a reminder, this conference call is being recorded.

Operator It is now my pleasure to introduce Gerianne Sarte, Head of Investor Relations.

Operator Thank you. You may begin.

Gerianne Sarte Investor Relations Officer Good afternoon, and thank you for joining us.

Gerianne Sarte Investor Relations Officer With me on today's call is our CEO, Bernard Zovighian; and our CFO, Doretta Mistras.

Gerianne Sarte Investor Relations Officer Also joining us for the Q&A portion of the call will be Dan Lippis, our Global Leader of TAVR; and Daveen Chopra, who has global responsibility for TMTT, Surgical and IHFM.

Gerianne Sarte Investor Relations Officer After the close of regular trading, Edwards Lifesciences released second quarter 2026 financial results.

Gerianne Sarte Investor Relations Officer During today's call, management will discuss the results included in the press release and accompanying financial schedules and then use the remaining time for Q&A.

Gerianne Sarte Investor Relations Officer Please note that management will be making forward-looking statements that are based on estimates, assumptions and projections.

Gerianne Sarte Investor Relations Officer These statements speak only as of the date on which they are made, and Edwards does not undertake any obligation to update them after today.

Gerianne Sarte Investor Relations Officer Additionally, the statements involve risks and uncertainties that could